Brief: Fluidigm Completes $250 Million Strategic Capital Infusion And Changes Name To Standard Biotools Inc
April 4 (Reuters) - Standard Biotools Inc FLDM.O :
* FLUIDIGM COMPLETES $250 MILLION STRATEGIC CAPITAL INFUSION
AND
CHANGES NAME TO STANDARD BIOTOOLS INC
Source text for Eikon: ID:nGNX13XCy8
Further company coverage: FLDM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07